Patient’s Name
Today’s Date
Reset
Print
ℹ
To save a PDF:
Click "Print", and select "Print to PDF"
Non-invasive French Criteria
5 year transplant-free survival was estimated based on the number of low-risk criteria present at first follow-up.
1
Select all values that apply.
Low Risk
Intermediate Risk
High Risk
Functional
Class
6-Minute
Walk Test
NT-proBNP
NT-proBNP
NT-proBNP/
BNP
BNP 50-300 ng/L
BNP >300 ng/L
How many low-risk goals
has your patient met today?
0
I, II
III
IV
0
>440 m
165-440 m
<165 m
0
NT-proBNP
<300 ng/L
—
BNP <50 ng /L
NT-proBNP 300-1400 ng/L
—
BNP 50-300 ng/L
NT-proBNP
>1400 ng/L
—
BNP >300 ng/L
0
All use subject to terms and conditions at www.unither.com/terms.html
References:1.
Boucly A, Weatherald J, Savale L, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J 2017; 50: 1700889 [https://doi.org/10.1183/13993003.00889-2017].
Sponsored by United Therapeutics
Committed to Improving the Lives of Patients
©2020 United Therapeutics Corporation. All rights reserved. US-DS-0553